Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management
SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) -- At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (“Fangzhou” or the “Company”)...
Day: September 14, 2025
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical...
Federal Legal Marijuana? MMJ’s Billion Dollar Trajectory: We’re Not Selling Marijuana, We’re Capturing a Market
MMJ International Holdings Is Betting on Medicine, Not MarijuanaIs Pharmaceutical Grade Cannabis Aiming for the Next Blockbuster?Duane Boise, MMJ's CEO...